United States Subcutaneous Biologics Industry 2016 Market Research Report
The United States Subcutaneous Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Subcutaneous Biologics industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Subcutaneous Biologics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Subcutaneous Biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 141 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Subcutaneous Biologics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Subcutaneous Biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 141 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW
1.1 Definition and Specifications of Subcutaneous Biologics
1.1.1 Definition of Subcutaneous Biologics
1.1.2 Specifications of Subcutaneous Biologics
1.2 Classification of Subcutaneous Biologics
1.2.1 Insulin Pumps with Infusion Sets
1.2.2 Insulin Patch Pumps
1.2.3 Transdermal Patch
1.2.4 Bolus Injectors
1.3 Applications of Subcutaneous Biologics
1.4 Industry Chain Structure of Subcutaneous Biologics
1.5 Industry Overview of Subcutaneous Biologics
1.6 Industry Policy Analysis of Subcutaneous Biologics
1.7 Industry News Analysis of Subcutaneous Biologics
2 MANUFACTURING COST STRUCTURE ANALYSIS OF SUBCUTANEOUS BIOLOGICS
2.1 Bill of Materials (BOM) of Subcutaneous Biologics
2.2 BOM Price Analysis of Subcutaneous Biologics
2.3 Labor Cost Analysis of Subcutaneous Biologics
2.4 Depreciation Cost Analysis of Subcutaneous Biologics
2.5 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.6 Manufacturing Process Analysis of Subcutaneous Biologics
2.7 United States Price, Cost and Gross of Subcutaneous Biologics 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015
4 PRODUCTION ANALYSIS OF SUBCUTANEOUS BIOLOGICS BY REGIONS, TYPE, AND APPLICATIONS
4.1 United States Production of Subcutaneous Biologics by Regions 2011-2016
4.2 United States Production of Subcutaneous Biologics by Type 2011-2016
4.3 United States Sales of Subcutaneous Biologics by Applications 2011-2016
4.4 Price Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Subcutaneous Biologics 2011-2016
5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF SUBCUTANEOUS BIOLOGICS BY REGIONS
5.1 United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016
5.2 United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016
5.3 United States Consumption Price Analysis of Subcutaneous Biologics by Regions 2011-2016
6 ANALYSIS OF SUBCUTANEOUS BIOLOGICS PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Subcutaneous Biologics 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Subcutaneous Biologics 2014-2015
6.3 Sales Overview of Subcutaneous Biologics 2011-2016
6.4 Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016
6.5 Import, Export and Consumption of Subcutaneous Biologics 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2011-2016
7 ANALYSIS OF SUBCUTANEOUS BIOLOGICS INDUSTRY KEY MANUFACTURERS
7.1 Abbott Laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Activa
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Adamis Pharmaceuticals Corporation
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 ADOCIA
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Advantage Health Services
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Aguettant
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Ajinomoto Althea Inc.
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Alnylam Pharmaceuticals
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Amgen
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 Antares Pharma
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
7.11 Aptar Pharm
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.2.1 Type I
7.11.2.2 Type II
7.11.2.3 Type III
7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
7.11.4 Contact Information
7.12 Aradigm Corporation
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.2.1 Type I
7.12.2.2 Type II
7.12.2.3 Type III
7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
7.12.4 Contact Information
7.13 Arte Corporation
7.13.1 Company Profile
7.13.2 Product Picture and Specifications
7.13.2.1 Type I
7.13.2.2 Type II
7.13.2.3 Type III
7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
7.13.4 Contact Information
7.14 Ascendis Pharma
7.14.1 Company Profile
7.14.2 Product Picture and Specifications
7.14.2.1 Type I
7.14.2.2 Type II
7.14.2.3 Type III
7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
7.14.4 Contact Information
7.15 AstraZeneca
7.15.1 Company Profile
7.15.2 Product Picture and Specifications
7.15.2.1 Type I
7.15.2.2 Type II
7.15.2.3 Type III
7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
7.15.4 Contact Information
7.16 Bang and Olufsen
7.16.1 Company Profile
7.16.2 Product Picture and Specifications
7.16.2.1 Type I
7.16.2.2 Type II
7.16.2.3 Type III
7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
7.16.4 Contact Information
7.17 Battelle
7.17.1 Company Profile
7.17.2 Product Picture and Specifications
7.17.2.1 Type I
7.17.2.2 Type II
7.17.2.3 Type III
7.17.3 Capacity, Production, Price, Cost, Gross and Revenue
7.17.4 Contact Information
7.18 Baxter
7.18.1 Company Profile
7.18.2 Product Picture and Specifications
7.18.2.1 Type I
7.18.2.2 Type II
7.18.2.3 Type III
7.18.3 Capacity, Production, Price, Cost, Gross and Revenue
7.18.4 Contact Information
7.19 Bayer
7.19.1 Company Profile
7.19.2 Product Picture and Specifications
7.19.2.1 Type I
7.19.2.2 Type II
7.19.2.3 Type III
7.19.3 Capacity, Production, Price, Cost, Gross and Revenue
7.19.4 Contact Information
7.20 Becton Dickinson
7.20.1 Company Profile
7.20.2 Product Picture and Specifications
7.20.2.1 Type I
7.20.2.2 Type II
7.20.2.3 Type III
7.20.3 Capacity, Production, Price, Cost, Gross and Revenue
7.20.4 Contact Information
7.21 Bespak
7.21.1 Company Profile
7.21.2 Product Picture and Specifications
7.21.2.1 Type I
7.21.2.2 Type II
7.21.2.3 Type III
7.21.3 Capacity, Production, Price, Cost, Gross and Revenue
7.21.4 Contact Information
7.22 Biogen Idec
7.22.1 Company Profile
7.22.2 Product Picture and Specifications
7.22.2.1 Type I
7.22.2.2 Type II
7.22.2.3 Type III
7.22.3 Capacity, Production, Price, Cost, Gross and Revenue
7.22.4 Contact Information
7.23 Bioject Medical Technologies, Inc.
7.23.1 Company Profile
7.23.2 Product Picture and Specifications
7.23.2.1 Type I
7.23.2.2 Type II
7.23.2.3 Type III
7.23.3 Capacity, Production, Price, Cost, Gross and Revenue
7.23.4 Contact Information
7.24 Bristol-Myers Squibb Co
7.24.1 Company Profile
7.24.2 Product Picture and Specifications
7.24.2.1 Type I
7.24.2.2 Type II
7.24.2.3 Type III
7.24.3 Capacity, Production, Price, Cost, Gross and Revenue
7.24.4 Contact Information
7.25 Calibra Medical
7.25.1 Company Profile
7.25.2 Product Picture and Specifications
7.25.2.1 Type I
7.25.2.2 Type II
7.25.2.3 Type III
7.25.3 Capacity, Production, Price, Cost, Gross and Revenue
7.25.4 Contact Information
7.26 CeQur SA
7.26.1 Company Profile
7.26.2 Product Picture and Specifications
7.26.2.1 Type I
7.26.2.2 Type II
7.26.2.3 Type III
7.26.3 Capacity, Production, Price, Cost, Gross and Revenue
7.26.4 Contact Information
8 PRICE AND GROSS MARGIN ANALYSIS
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Subcutaneous Biologics Product Types
8.5 Market Share Analysis of Different Subcutaneous Biologics Price Levels
8.6 Gross Margin Analysis of Different Subcutaneous Biologics Applications
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF SUBCUTANEOUS BIOLOGICS
9.1 Marketing Channels Status of Subcutaneous Biologics
9.2 Traders or Distributors of Subcutaneous Biologics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Subcutaneous Biologics
9.4 United States Import, Export and Trade Analysis of Subcutaneous Biologics
10 DEVELOPMENT TREND OF SUBCUTANEOUS BIOLOGICS INDUSTRY 2016-2021
10.1 Capacity and Production Overview of Subcutaneous Biologics 2016-2021
10.2 Production Market Share by Product Types of Subcutaneous Biologics 2016-2021
10.3 Sales and Sales Revenue Overview of Subcutaneous Biologics 2016-2021
10.4 United States Sales of Subcutaneous Biologics by Applications 2016-2021
10.5 Import, Export and Consumption of Subcutaneous Biologics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2016-2021
11 INDUSTRY CHAIN SUPPLIERS OF SUBCUTANEOUS BIOLOGICS WITH CONTACT INFORMATION
11.1 Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
11.2 Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
11.3 Major Players of Subcutaneous Biologics with Contact Information
11.4 Key Consumers of Subcutaneous Biologics with Contact Information
11.5 Supply Chain Relationship Analysis of Subcutaneous Biologics
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF SUBCUTANEOUS BIOLOGICS
12.1 New Project SWOT Analysis of Subcutaneous Biologics
12.2 New Project Investment Feasibility Analysis of Subcutaneous Biologics
13 CONCLUSION OF THE UNITED STATES SUBCUTANEOUS BIOLOGICS INDUSTRY 2016 MARKET RESEARCH REPORT
1.1 Definition and Specifications of Subcutaneous Biologics
1.1.1 Definition of Subcutaneous Biologics
1.1.2 Specifications of Subcutaneous Biologics
1.2 Classification of Subcutaneous Biologics
1.2.1 Insulin Pumps with Infusion Sets
1.2.2 Insulin Patch Pumps
1.2.3 Transdermal Patch
1.2.4 Bolus Injectors
1.3 Applications of Subcutaneous Biologics
1.4 Industry Chain Structure of Subcutaneous Biologics
1.5 Industry Overview of Subcutaneous Biologics
1.6 Industry Policy Analysis of Subcutaneous Biologics
1.7 Industry News Analysis of Subcutaneous Biologics
2 MANUFACTURING COST STRUCTURE ANALYSIS OF SUBCUTANEOUS BIOLOGICS
2.1 Bill of Materials (BOM) of Subcutaneous Biologics
2.2 BOM Price Analysis of Subcutaneous Biologics
2.3 Labor Cost Analysis of Subcutaneous Biologics
2.4 Depreciation Cost Analysis of Subcutaneous Biologics
2.5 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.6 Manufacturing Process Analysis of Subcutaneous Biologics
2.7 United States Price, Cost and Gross of Subcutaneous Biologics 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015
4 PRODUCTION ANALYSIS OF SUBCUTANEOUS BIOLOGICS BY REGIONS, TYPE, AND APPLICATIONS
4.1 United States Production of Subcutaneous Biologics by Regions 2011-2016
4.2 United States Production of Subcutaneous Biologics by Type 2011-2016
4.3 United States Sales of Subcutaneous Biologics by Applications 2011-2016
4.4 Price Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Subcutaneous Biologics 2011-2016
5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF SUBCUTANEOUS BIOLOGICS BY REGIONS
5.1 United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016
5.2 United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016
5.3 United States Consumption Price Analysis of Subcutaneous Biologics by Regions 2011-2016
6 ANALYSIS OF SUBCUTANEOUS BIOLOGICS PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Subcutaneous Biologics 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Subcutaneous Biologics 2014-2015
6.3 Sales Overview of Subcutaneous Biologics 2011-2016
6.4 Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016
6.5 Import, Export and Consumption of Subcutaneous Biologics 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2011-2016
7 ANALYSIS OF SUBCUTANEOUS BIOLOGICS INDUSTRY KEY MANUFACTURERS
7.1 Abbott Laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Activa
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Adamis Pharmaceuticals Corporation
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 ADOCIA
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Advantage Health Services
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Aguettant
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Ajinomoto Althea Inc.
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Alnylam Pharmaceuticals
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Amgen
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 Antares Pharma
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
7.11 Aptar Pharm
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.2.1 Type I
7.11.2.2 Type II
7.11.2.3 Type III
7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
7.11.4 Contact Information
7.12 Aradigm Corporation
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.2.1 Type I
7.12.2.2 Type II
7.12.2.3 Type III
7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
7.12.4 Contact Information
7.13 Arte Corporation
7.13.1 Company Profile
7.13.2 Product Picture and Specifications
7.13.2.1 Type I
7.13.2.2 Type II
7.13.2.3 Type III
7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
7.13.4 Contact Information
7.14 Ascendis Pharma
7.14.1 Company Profile
7.14.2 Product Picture and Specifications
7.14.2.1 Type I
7.14.2.2 Type II
7.14.2.3 Type III
7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
7.14.4 Contact Information
7.15 AstraZeneca
7.15.1 Company Profile
7.15.2 Product Picture and Specifications
7.15.2.1 Type I
7.15.2.2 Type II
7.15.2.3 Type III
7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
7.15.4 Contact Information
7.16 Bang and Olufsen
7.16.1 Company Profile
7.16.2 Product Picture and Specifications
7.16.2.1 Type I
7.16.2.2 Type II
7.16.2.3 Type III
7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
7.16.4 Contact Information
7.17 Battelle
7.17.1 Company Profile
7.17.2 Product Picture and Specifications
7.17.2.1 Type I
7.17.2.2 Type II
7.17.2.3 Type III
7.17.3 Capacity, Production, Price, Cost, Gross and Revenue
7.17.4 Contact Information
7.18 Baxter
7.18.1 Company Profile
7.18.2 Product Picture and Specifications
7.18.2.1 Type I
7.18.2.2 Type II
7.18.2.3 Type III
7.18.3 Capacity, Production, Price, Cost, Gross and Revenue
7.18.4 Contact Information
7.19 Bayer
7.19.1 Company Profile
7.19.2 Product Picture and Specifications
7.19.2.1 Type I
7.19.2.2 Type II
7.19.2.3 Type III
7.19.3 Capacity, Production, Price, Cost, Gross and Revenue
7.19.4 Contact Information
7.20 Becton Dickinson
7.20.1 Company Profile
7.20.2 Product Picture and Specifications
7.20.2.1 Type I
7.20.2.2 Type II
7.20.2.3 Type III
7.20.3 Capacity, Production, Price, Cost, Gross and Revenue
7.20.4 Contact Information
7.21 Bespak
7.21.1 Company Profile
7.21.2 Product Picture and Specifications
7.21.2.1 Type I
7.21.2.2 Type II
7.21.2.3 Type III
7.21.3 Capacity, Production, Price, Cost, Gross and Revenue
7.21.4 Contact Information
7.22 Biogen Idec
7.22.1 Company Profile
7.22.2 Product Picture and Specifications
7.22.2.1 Type I
7.22.2.2 Type II
7.22.2.3 Type III
7.22.3 Capacity, Production, Price, Cost, Gross and Revenue
7.22.4 Contact Information
7.23 Bioject Medical Technologies, Inc.
7.23.1 Company Profile
7.23.2 Product Picture and Specifications
7.23.2.1 Type I
7.23.2.2 Type II
7.23.2.3 Type III
7.23.3 Capacity, Production, Price, Cost, Gross and Revenue
7.23.4 Contact Information
7.24 Bristol-Myers Squibb Co
7.24.1 Company Profile
7.24.2 Product Picture and Specifications
7.24.2.1 Type I
7.24.2.2 Type II
7.24.2.3 Type III
7.24.3 Capacity, Production, Price, Cost, Gross and Revenue
7.24.4 Contact Information
7.25 Calibra Medical
7.25.1 Company Profile
7.25.2 Product Picture and Specifications
7.25.2.1 Type I
7.25.2.2 Type II
7.25.2.3 Type III
7.25.3 Capacity, Production, Price, Cost, Gross and Revenue
7.25.4 Contact Information
7.26 CeQur SA
7.26.1 Company Profile
7.26.2 Product Picture and Specifications
7.26.2.1 Type I
7.26.2.2 Type II
7.26.2.3 Type III
7.26.3 Capacity, Production, Price, Cost, Gross and Revenue
7.26.4 Contact Information
8 PRICE AND GROSS MARGIN ANALYSIS
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Subcutaneous Biologics Product Types
8.5 Market Share Analysis of Different Subcutaneous Biologics Price Levels
8.6 Gross Margin Analysis of Different Subcutaneous Biologics Applications
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF SUBCUTANEOUS BIOLOGICS
9.1 Marketing Channels Status of Subcutaneous Biologics
9.2 Traders or Distributors of Subcutaneous Biologics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Subcutaneous Biologics
9.4 United States Import, Export and Trade Analysis of Subcutaneous Biologics
10 DEVELOPMENT TREND OF SUBCUTANEOUS BIOLOGICS INDUSTRY 2016-2021
10.1 Capacity and Production Overview of Subcutaneous Biologics 2016-2021
10.2 Production Market Share by Product Types of Subcutaneous Biologics 2016-2021
10.3 Sales and Sales Revenue Overview of Subcutaneous Biologics 2016-2021
10.4 United States Sales of Subcutaneous Biologics by Applications 2016-2021
10.5 Import, Export and Consumption of Subcutaneous Biologics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2016-2021
11 INDUSTRY CHAIN SUPPLIERS OF SUBCUTANEOUS BIOLOGICS WITH CONTACT INFORMATION
11.1 Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
11.2 Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
11.3 Major Players of Subcutaneous Biologics with Contact Information
11.4 Key Consumers of Subcutaneous Biologics with Contact Information
11.5 Supply Chain Relationship Analysis of Subcutaneous Biologics
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF SUBCUTANEOUS BIOLOGICS
12.1 New Project SWOT Analysis of Subcutaneous Biologics
12.2 New Project Investment Feasibility Analysis of Subcutaneous Biologics
13 CONCLUSION OF THE UNITED STATES SUBCUTANEOUS BIOLOGICS INDUSTRY 2016 MARKET RESEARCH REPORT
LIST OF TABLES AND FIGURES
Figure Picture of Subcutaneous Biologics
Table Product Specifications of Subcutaneous Biologics
Table Classification of Subcutaneous Biologics
Figure United States Sales Market Share of Subcutaneous Biologics by Product Types in 2015
Table Applications of Subcutaneous Biologics
Figure United States Sales Market Share of Subcutaneous Biologics by Applications in 2015
Figure Industry Chain Structure of Subcutaneous Biologics
Table United States Industry Overview of Subcutaneous Biologics
Table Industry Policy of Subcutaneous Biologics
Table Industry News List of Subcutaneous Biologics
Table Bill of Materials (BOM) of Subcutaneous Biologics
Table Bill of Materials (BOM) Price of Subcutaneous Biologics
Table Labor Cost of Subcutaneous Biologics
Table Depreciation Cost of Subcutaneous Biologics
Table Manufacturing Cost Structure Analysis of Subcutaneous Biologics in 2015
Figure Manufacturing Process Analysis of Subcutaneous Biologics
Table United States Price Analysis of Subcutaneous Biologics 2011-2016 (USD/Unit)
Table United States Cost Analysis of Subcutaneous Biologics 2011-2016 (USD/Unit)
Table United States Gross Analysis of Subcutaneous Biologics 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Subcutaneous Biologics Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015
Table R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Subcutaneous Biologics Key Manufacturers in 2015
Table United States Production of Subcutaneous Biologics by Regions 2011-2016 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Regions 2011-2016
Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2015
Table United States Production of Subcutaneous Biologics by Types in 2011-2016 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Type in 2011-2016
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2015
Table United States Sales of Subcutaneous Biologics by Applications 2011-2016 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Applications 2011-2016
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2015
Table Price Comparison of United States Subcutaneous Biologics Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Subcutaneous Biologics 2011-2016
Table United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Subcutaneous Biologics by Regions 2011-2016
Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2015
Table United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Subcutaneous Biologics by Regions 2011-2016
Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2015
Table Consumption Price of Subcutaneous Biologics by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Capacity Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Production Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Sales Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Subcutaneous Biologics 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2014
Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2015
Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2014
Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Table United States Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)
Table Price of United States Subcutaneous Biologics Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Subcutaneous Biologics Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Subcutaneous Biologics 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Abbott Laboratories
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Abbott Laboratories 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Abbott Laboratories 2011-2016
Table Abbott Laboratories Subcutaneous Biologics SWOT Analysis
Table Activa Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Activa
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Activa 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Activa 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Activa 2011-2016
Table Activa Subcutaneous Biologics SWOT Analysis
Table Adamis Pharmaceuticals Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Adamis Pharmaceuticals Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Adamis Pharmaceuticals Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Adamis Pharmaceuticals Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Adamis Pharmaceuticals Corporation 2011-2016
Table Adamis Pharmaceuticals Corporation Subcutaneous Biologics SWOT Analysis
Table ADOCIA Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of ADOCIA
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ADOCIA 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of ADOCIA 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of ADOCIA 2011-2016
Table ADOCIA Subcutaneous Biologics SWOT Analysis
Table Advantage Health Services Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Advantage Health Services
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Advantage Health Services 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Advantage Health Services 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Advantage Health Services 2011-2016
Table Advantage Health Services Subcutaneous Biologics SWOT Analysis
Table Aguettant Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Aguettant
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aguettant 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aguettant 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aguettant 2011-2016
Table Aguettant Subcutaneous Biologics SWOT Analysis
Table Ajinomoto Althea Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Ajinomoto Althea Inc.
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ajinomoto Althea Inc. 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ajinomoto Althea Inc. 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Ajinomoto Althea Inc. 2011-2016
Table Ajinomoto Althea Inc. Subcutaneous Biologics SWOT Analysis
Table Alnylam Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Alnylam Pharmaceuticals
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Alnylam Pharmaceuticals 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Alnylam Pharmaceuticals 2011-2016
Table Alnylam Pharmaceuticals Subcutaneous Biologics SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Amgen
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Amgen 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Amgen 2011-2016
Table Amgen Subcutaneous Biologics SWOT Analysis
Table Antares Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Antares Pharma
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Antares Pharma 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Antares Pharma 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Antares Pharma 2011-2016
Table Antares Pharma Subcutaneous Biologics SWOT Analysis
Table Aptar Pharm Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Aptar Pharm
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aptar Pharm 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aptar Pharm 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aptar Pharm 2011-2016
Table Aptar Pharm Subcutaneous Biologics SWOT Analysis
Table Aradigm Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Aradigm Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aradigm Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aradigm Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aradigm Corporation 2011-2016
Table Aradigm Corporation Subcutaneous Biologics SWOT Analysis
Table Arte Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Arte Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arte Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Arte Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Arte Corporation 2011-2016
Table Arte Corporation Subcutaneous Biologics SWOT Analysis
Table Ascendis Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Ascendis Pharma
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ascendis Pharma 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ascendis Pharma 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Ascendis Pharma 2011-2016
Table Ascendis Pharma Subcutaneous Biologics SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of AstraZeneca
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of AstraZeneca 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of AstraZeneca 2011-2016
Table AstraZeneca Subcutaneous Biologics SWOT Analysis
Table Bang and Olufsen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bang and Olufsen
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bang and Olufsen 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bang and Olufsen 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bang and Olufsen 2011-2016
Table Bang and Olufsen Subcutaneous Biologics SWOT Analysis
Table Battelle Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Battelle
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Battelle 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Battelle 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Battelle 2011-2016
Table Battelle Subcutaneous Biologics SWOT Analysis
Table Baxter Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Baxter
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Baxter 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Baxter 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Baxter 2011-2016
Table Baxter Subcutaneous Biologics SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bayer
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bayer 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bayer 2011-2016
Table Bayer Subcutaneous Biologics SWOT Analysis
Table Becton Dickinson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Becton Dickinson
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Becton Dickinson 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Becton Dickinson 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Becton Dickinson 2011-2016
Table Becton Dickinson Subcutaneous Biologics SWOT Analysis
Table Bespak Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bespak
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bespak 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bespak 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bespak 2011-2016
Table Bespak Subcutaneous Biologics SWOT Analysis
Table Biogen Idec Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Biogen Idec
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen Idec 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Biogen Idec 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Biogen Idec 2011-2016
Table Biogen Idec Subcutaneous Biologics SWOT Analysis
Table Bioject Medical Technologies, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bioject Medical Technologies, Inc.
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bioject Medical Technologies, Inc. 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bioject Medical Technologies, Inc. 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bioject Medical Technologies, Inc. 2011-2016
Table Bioject Medical Technologies, Inc. Subcutaneous Biologics SWOT Analysis
Table Bristol-Myers Squibb Co Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bristol-Myers Squibb Co
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb Co 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bristol-Myers Squibb Co 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bristol-Myers Squibb Co 2011-2016
Table Bristol-Myers Squibb Co Subcutaneous Biologics SWOT Analysis
Table Calibra Medical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Calibra Medical
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Calibra Medical 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Calibra Medical 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Calibra Medical 2011-2016
Table Calibra Medical Subcutaneous Biologics SWOT Analysis
Table CeQur SA Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of CeQur SA
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CeQur SA 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of CeQur SA 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of CeQur SA 2011-2016
Table CeQur SA Subcutaneous Biologics SWOT Analysis
Table Subcutaneous Biologics Price by Regions 2011-2016
Table Subcutaneous Biologics Price by Product Types 2011-2016
Table Subcutaneous Biologics Price by Companies 2011-2016
Table Subcutaneous Biologics Gross Margin by Companies 2011-2016
Table Price Comparison of Subcutaneous Biologics by Regions 2011-2016 (USD/Unit)
Table Price of Different Subcutaneous Biologics Product Types (USD/Unit)
Table Market Share of Different Subcutaneous Biologics Price Level
Table Gross Margin of Different Subcutaneous Biologics Applications
Table Marketing Channels Status of Subcutaneous Biologics
Table Traders or Distributors of Subcutaneous Biologics with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Subcutaneous Biologics (USD/Unit) in 2015
Table United States Import, Export, and Trade of Subcutaneous Biologics (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Table United States Subcutaneous Biologics Production by Type 2016-2021 (Unit)
Table United States Subcutaneous Biologics Production Market Share by Type 2016-2021
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Sales of Subcutaneous Biologics by Applications 2016-2021 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Applications 2016-2021
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2021
Table United States Production, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
Table Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
Table Major Players of Subcutaneous Biologics with Contact Information
Table Key Consumers of Subcutaneous Biologics with Contact Information
Table Supply Chain Relationship Analysis of Subcutaneous Biologics
Table New Project SWOT Analysis of Subcutaneous Biologics
Table New Project Investment Feasibility Analysis of Subcutaneous Biologics
Table Part of Interviewees Record List
Figure Picture of Subcutaneous Biologics
Table Product Specifications of Subcutaneous Biologics
Table Classification of Subcutaneous Biologics
Figure United States Sales Market Share of Subcutaneous Biologics by Product Types in 2015
Table Applications of Subcutaneous Biologics
Figure United States Sales Market Share of Subcutaneous Biologics by Applications in 2015
Figure Industry Chain Structure of Subcutaneous Biologics
Table United States Industry Overview of Subcutaneous Biologics
Table Industry Policy of Subcutaneous Biologics
Table Industry News List of Subcutaneous Biologics
Table Bill of Materials (BOM) of Subcutaneous Biologics
Table Bill of Materials (BOM) Price of Subcutaneous Biologics
Table Labor Cost of Subcutaneous Biologics
Table Depreciation Cost of Subcutaneous Biologics
Table Manufacturing Cost Structure Analysis of Subcutaneous Biologics in 2015
Figure Manufacturing Process Analysis of Subcutaneous Biologics
Table United States Price Analysis of Subcutaneous Biologics 2011-2016 (USD/Unit)
Table United States Cost Analysis of Subcutaneous Biologics 2011-2016 (USD/Unit)
Table United States Gross Analysis of Subcutaneous Biologics 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Subcutaneous Biologics Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015
Table R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Subcutaneous Biologics Key Manufacturers in 2015
Table United States Production of Subcutaneous Biologics by Regions 2011-2016 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Regions 2011-2016
Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2015
Table United States Production of Subcutaneous Biologics by Types in 2011-2016 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Type in 2011-2016
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2015
Table United States Sales of Subcutaneous Biologics by Applications 2011-2016 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Applications 2011-2016
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2014
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2015
Table Price Comparison of United States Subcutaneous Biologics Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Subcutaneous Biologics 2011-2016
Table United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Subcutaneous Biologics by Regions 2011-2016
Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2015
Table United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Subcutaneous Biologics by Regions 2011-2016
Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2014
Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2015
Table Consumption Price of Subcutaneous Biologics by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Capacity Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Production Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Sales Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Subcutaneous Biologics 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2014
Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2015
Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2014
Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Table United States Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table United States Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)
Table Price of United States Subcutaneous Biologics Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Subcutaneous Biologics Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Subcutaneous Biologics 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Abbott Laboratories
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Abbott Laboratories 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Abbott Laboratories 2011-2016
Table Abbott Laboratories Subcutaneous Biologics SWOT Analysis
Table Activa Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Activa
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Activa 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Activa 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Activa 2011-2016
Table Activa Subcutaneous Biologics SWOT Analysis
Table Adamis Pharmaceuticals Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Adamis Pharmaceuticals Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Adamis Pharmaceuticals Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Adamis Pharmaceuticals Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Adamis Pharmaceuticals Corporation 2011-2016
Table Adamis Pharmaceuticals Corporation Subcutaneous Biologics SWOT Analysis
Table ADOCIA Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of ADOCIA
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ADOCIA 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of ADOCIA 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of ADOCIA 2011-2016
Table ADOCIA Subcutaneous Biologics SWOT Analysis
Table Advantage Health Services Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Advantage Health Services
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Advantage Health Services 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Advantage Health Services 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Advantage Health Services 2011-2016
Table Advantage Health Services Subcutaneous Biologics SWOT Analysis
Table Aguettant Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Aguettant
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aguettant 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aguettant 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aguettant 2011-2016
Table Aguettant Subcutaneous Biologics SWOT Analysis
Table Ajinomoto Althea Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Ajinomoto Althea Inc.
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ajinomoto Althea Inc. 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ajinomoto Althea Inc. 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Ajinomoto Althea Inc. 2011-2016
Table Ajinomoto Althea Inc. Subcutaneous Biologics SWOT Analysis
Table Alnylam Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Alnylam Pharmaceuticals
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Alnylam Pharmaceuticals 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Alnylam Pharmaceuticals 2011-2016
Table Alnylam Pharmaceuticals Subcutaneous Biologics SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Amgen
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Amgen 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Amgen 2011-2016
Table Amgen Subcutaneous Biologics SWOT Analysis
Table Antares Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Antares Pharma
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Antares Pharma 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Antares Pharma 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Antares Pharma 2011-2016
Table Antares Pharma Subcutaneous Biologics SWOT Analysis
Table Aptar Pharm Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Aptar Pharm
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aptar Pharm 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aptar Pharm 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aptar Pharm 2011-2016
Table Aptar Pharm Subcutaneous Biologics SWOT Analysis
Table Aradigm Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Aradigm Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aradigm Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aradigm Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aradigm Corporation 2011-2016
Table Aradigm Corporation Subcutaneous Biologics SWOT Analysis
Table Arte Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Arte Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arte Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Arte Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Arte Corporation 2011-2016
Table Arte Corporation Subcutaneous Biologics SWOT Analysis
Table Ascendis Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Ascendis Pharma
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ascendis Pharma 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ascendis Pharma 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Ascendis Pharma 2011-2016
Table Ascendis Pharma Subcutaneous Biologics SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of AstraZeneca
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of AstraZeneca 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of AstraZeneca 2011-2016
Table AstraZeneca Subcutaneous Biologics SWOT Analysis
Table Bang and Olufsen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bang and Olufsen
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bang and Olufsen 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bang and Olufsen 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bang and Olufsen 2011-2016
Table Bang and Olufsen Subcutaneous Biologics SWOT Analysis
Table Battelle Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Battelle
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Battelle 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Battelle 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Battelle 2011-2016
Table Battelle Subcutaneous Biologics SWOT Analysis
Table Baxter Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Baxter
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Baxter 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Baxter 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Baxter 2011-2016
Table Baxter Subcutaneous Biologics SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bayer
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bayer 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bayer 2011-2016
Table Bayer Subcutaneous Biologics SWOT Analysis
Table Becton Dickinson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Becton Dickinson
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Becton Dickinson 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Becton Dickinson 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Becton Dickinson 2011-2016
Table Becton Dickinson Subcutaneous Biologics SWOT Analysis
Table Bespak Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bespak
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bespak 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bespak 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bespak 2011-2016
Table Bespak Subcutaneous Biologics SWOT Analysis
Table Biogen Idec Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Biogen Idec
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen Idec 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Biogen Idec 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Biogen Idec 2011-2016
Table Biogen Idec Subcutaneous Biologics SWOT Analysis
Table Bioject Medical Technologies, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bioject Medical Technologies, Inc.
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bioject Medical Technologies, Inc. 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bioject Medical Technologies, Inc. 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bioject Medical Technologies, Inc. 2011-2016
Table Bioject Medical Technologies, Inc. Subcutaneous Biologics SWOT Analysis
Table Bristol-Myers Squibb Co Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Bristol-Myers Squibb Co
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb Co 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bristol-Myers Squibb Co 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bristol-Myers Squibb Co 2011-2016
Table Bristol-Myers Squibb Co Subcutaneous Biologics SWOT Analysis
Table Calibra Medical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of Calibra Medical
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Calibra Medical 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Calibra Medical 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Calibra Medical 2011-2016
Table Calibra Medical Subcutaneous Biologics SWOT Analysis
Table CeQur SA Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Subcutaneous Biologics Picture and Specifications of CeQur SA
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CeQur SA 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of CeQur SA 2011-2016
Figure Subcutaneous Biologics Production (Unit) and United States Market Share of CeQur SA 2011-2016
Table CeQur SA Subcutaneous Biologics SWOT Analysis
Table Subcutaneous Biologics Price by Regions 2011-2016
Table Subcutaneous Biologics Price by Product Types 2011-2016
Table Subcutaneous Biologics Price by Companies 2011-2016
Table Subcutaneous Biologics Gross Margin by Companies 2011-2016
Table Price Comparison of Subcutaneous Biologics by Regions 2011-2016 (USD/Unit)
Table Price of Different Subcutaneous Biologics Product Types (USD/Unit)
Table Market Share of Different Subcutaneous Biologics Price Level
Table Gross Margin of Different Subcutaneous Biologics Applications
Table Marketing Channels Status of Subcutaneous Biologics
Table Traders or Distributors of Subcutaneous Biologics with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Subcutaneous Biologics (USD/Unit) in 2015
Table United States Import, Export, and Trade of Subcutaneous Biologics (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Table United States Subcutaneous Biologics Production by Type 2016-2021 (Unit)
Table United States Subcutaneous Biologics Production Market Share by Type 2016-2021
Figure United States Production Market Share of Subcutaneous Biologics by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure United States Sales of Subcutaneous Biologics by Applications 2016-2021 (Unit)
Table United States Production Market Share of Subcutaneous Biologics by Applications 2016-2021
Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2021
Table United States Production, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
Table Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
Table Major Players of Subcutaneous Biologics with Contact Information
Table Key Consumers of Subcutaneous Biologics with Contact Information
Table Supply Chain Relationship Analysis of Subcutaneous Biologics
Table New Project SWOT Analysis of Subcutaneous Biologics
Table New Project Investment Feasibility Analysis of Subcutaneous Biologics
Table Part of Interviewees Record List
